US2015110908A1PendingUtilityA1

Compositions, Kits, and Methods for Ameliorating Oculoplastic Post-Procedural Effects

65
Assignee: OCUSOFT INCPriority: Oct 21, 2013Filed: Oct 21, 2013Published: Apr 23, 2015
Est. expiryOct 21, 2033(~7.2 yrs left)· nominal 20-yr term from priority
Inventors:Nat Adkins, Jr.
A61K 31/704A61K 31/122A61K 36/28A61K 31/19A61K 47/14A61K 47/12A61K 31/593A61K 47/44A61K 31/665A61K 31/4166A61K 9/0014A61K 31/085A61K 47/10A61K 47/02A61K 31/355A61K 47/34A61K 47/24A61K 31/23A61K 47/36
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Embodiments of the invention are directed to compositions, kits and methods for minimizing unsightly post-procedural effects associated with an oculoplastic procedure. The composition can include escin, arnica and phytonadione in a pharmacologically acceptable carrier.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A topical composition comprising:
 escin;     arnica;  and   phytonadione,   wherein the composition is formulated to minimize one or more post-procedural effects associated with an oculoplastic procedure.   
     
     
         2 . The composition according to  claim 1 , further comprising deionized water. 
     
     
         3 . The composition according to  claim 1 , further comprising glycerin. 
     
     
         4 . The composition according to  claim 1 , further comprising glycerin stearate and/or glyceryl stearate citrate. 
     
     
         5 . The composition according to  claim 1 , further comprising:
 stearic acid;   sunflower oil;   phenoxyethanol;   dimethicone;   tocopheryl acetate;   allantoin;   retinyl palmitate;   cholecalciferol;   sodium ascorbyl phosphate;   cetearyl alcohol;   lecithin;   potassium sorbate; and   caprylic/capric triglyceride.   
     
     
         6 . The composition according to  claim 1 , further comprising xanthan gum. 
     
     
         7 . The composition according to  claim 1 , further comprising sodium bicarbonate. 
     
     
         8 . A method of minimizing one or more post-procedural effects associated with an oculoplastic procedure in a subject, comprising:
 administering a therapeutically effective amount of a composition comprising:
 escin; 
   arnica;  and 
 phytonadione. 
   
     
     
         9 . The method according to  claim 8 , wherein the composition is administered after the oculoplastic procedure. 
     
     
         10 . The method according to  claim 8 , wherein the composition is administered prior to the oculoplastic procedure. 
     
     
         11 . The method according to  claim 8 , wherein the composition further comprises glycerin, stearate and/or glyceryl stearate citrate. 
     
     
         12 . The method according to  claim 8 , wherein the composition further comprises:
 deionized water;   stearic acid;   sunflower oil;   phenoxyethanol;   dimethicone;   tocopheryl acetate;   allantoin;   retinyl palmitate;   cholecalciferol;   sodium ascorbyl phosphate;   cetearyl alcohol;   lecithin;   xanthan gum;   potassium sorbate; and   caprylic triglyceride.   
     
     
         13 . The method according to  claim 8 , wherein the oculoplastic procedure comprises a facial procedure. 
     
     
         14 . The method according to  claim 8 , wherein the composition is topically applied to the skin. 
     
     
         15 . The method according to  claim 8 , wherein the composition is topically applied at or around a site of the oculoplastic procedure. 
     
     
         16 . The method according to  claim 8 , wherein the composition is administered in a pharmacologically acceptable form selected from creams, ointments, gels, lotions, solutions and emulsions. 
     
     
         17 . The method according to  claim 8 , wherein the applied amount of the composition is sufficient to reduce the healing time of a post-procedural bruise and/or scar. 
     
     
         18 . The method according to  claim 8 , further comprises identifying a patient recommended for an oculoplastic procedure. 
     
     
         19 . A post-oculoplastic procedure recovery kit comprising:
 a topical composition consisting essentially of:   escin;     arnica;      phytonadione;   glycerin stearate;   glyceryl stearate citrate;   glycerin;   stearic acid;   sunflower oil;   phenoxyethanol;   dimethicone;   tocopheryl acetate;   allantoin;   retinyl palmitate;   cholecalciferol;   sodium ascorbyl phosphate;   cetearyl alcohol;   lecithin;   potassium sorbate;   caprylic triglyceride;   xanthan gum;   sodium bicarbonate; and   deionized water,
 wherein the composition is formulated to minimize one or more post-procedural effects associated with an oculoplastic procedure. 
   
     
     
         20 . The kit according to  claim 19 , wherein the kit further comprises housing for the topical composition.

Join the waitlist — get patent alerts

Track US2015110908A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.